My name is Ana Vankova, I'm 26 and I come from Skopje, Macedonia. I obtained my BSc degree in Chemical Engineering (Analytical Biochemistry) in Skopje. After finishing my degree, I worked in food quality control for a year and a half before moving to Trondheim, Norway, to pursue a Master's in Molecular Medicine at the [...]
Hello! My name is Leonie Toorman. I am 22 years old originally from the Netherlands, but currently living in Vienna, Austria. I have always had a great interest in what makes us who we are, the effects that biology and our environment have on our lives, and what we can do to make ourselves [...]
I'm Olimpia, I'm 26 years old and I was born in Udine, Italy. I completed a Bachelor's for Interpreters in Padua, Italy, before moving to Vienna, Austria to study for a Master's in Translation. I have taken on several volunteering causes since I moved to Vienna. I love the extraordinary ties of friendship and respect that can come out from [...]
My name is Desislava Manolova, but my friends call me Dessi. I was born 1991 in Pazardzhik, a small town in South Bulgaria, where I grew up. After graduating from high school, at the age of 19, I moved to Austria with my best friend. My intention was to attend university but due to my financial situation, I couldn't do it [...]
I’m Beyza Bürüngüz Schmidt, I am 35, and I am from in Istanbul, Turkey. I’m a person who takes good care of her health and generally-speaking interested in holistic health. I hold a Bachelor’s in Business Administration from Istanbul Yeditepe University (Turkey) and a Certificate in Business from Vancouver English Center (BC, Canada). Interested [...]
I'm Pasan Wijesinghe, 24 years old, and I'm from Sri Lanka. I am currently studying toward a double major: a Bachelor's in Biomedical Sciences at Northumbria University (Newcastle upon Tyne, UK) and a Bachelor's in Chemistry at the Institute of Chemistry Ceylon (Sri Jayawardenapura Kotte, Sri Lanka). I am a Junior Member of [...]
Hi, my name is Michael Wachtel, I'm 34 and I'm from Vienna, Austria. I’m currently studying molecular biotechnology at the Technical University FH Campus Vienna. Prior to my current studies, I worked in many different professional sectors, including office management, IT, and the pharmaceutical industry. I became aware of the work done by the [...]
My name is Sanja and I was born in 1978 in Croatia, at the time, still part of Yugoslavia. A bit about me professionally: education has always been important in my family, and I hold two Bachelor's degrees: one in Agriculture and another in Environmental studies. I've worked for 15 years in laboratories of [...]
My name is Petra Haumer, I'm 26 years old and I'm from Austria. I grew up in a small village on the Czech border before moving to Vienna. I now study Czech and Russian and aim to become a teacher for these two languages. I also work in an communication agency and my responsibilities [...]
My name is Omnia, I am 37, and I am an Egyptian pediatric oncologist. From early on, my parents fought hard so that my sister, brother and I have the best possible life and that we excel in our respective careers. My parents’ vision, in fact my family’s vision, has always been to be [...]
My name is Leonora Rrahmani Ramabaja, and I was born on 03.05.1986 in Ferizaj, Republic of Kosovo. I hold a Bachelor's degree in Political Science and Public administration from University of Pristina (Pristina, Kosovo), and a Master's degree in Public Policy from Rochester Institute of Technology (Rochester, NY, USA). I am currently a doctoral candidate at the [...]
I am Yordanka (Danny) Tanova and I am 26 years old. I am originally from Pazardzhik and now live in Plovdiv, Bulgaria. I hold a Master's degree in Business Informatics. I work as a Software Quality Assurance tester and I am also a mom. I volunteer at the Cancer Epigenetics Society since 02/2018 as [...]
Unexpected findings in early-stage breast cancer initiation thanks to epigenetic editing. Research conducted at the Queen Mary University of London by Cancer Epigenetics Society Member, Dr. Gabriella Ficz and her collaborators, shows that an epigenetic alteration of just one gene is sufficient to drive normal breast cells to pre-neoplastic stages, a discovery that may [...]
The Cancer Epigenetics Society is happy to announce the appointment of Dr. Stephan Beck to the Editorial Board of Cancer Epigenetics. Dr. Stephan Beck is Professor of Medical Genomics at University College London Cancer Institute (London, UK), and is one of the pioneers and a leader of the field of epigenomics. [...]
The Cancer Epigenetics Society is happy to announce the appointment of Dr. Ayalew Tefferi to the Editorial Board of Clinical Cancer Epigenetics. Dr. Tefferi is Professor of Hematology and of Internal Medicine at the Mayo Clinic (Rochester, MN, USA). He also serves as a Board Review Course Faculty at MD Anderson Cancer Center, George [...]
The Cancer Epigenetics Society is happy to announce the appointment of Dr. Owen A. O'Connor to the Editorial Board of Clinical Cancer Epigenetics. Dr. O’Connor is Professor of Medicine and Experimental Therapeutics at Columbia University and Director of the Center for Lymphoid Malignancies at the Herbert Irving Comprehensive Cancer Center (New York, NY, USA). [...]
The Cancer Epigenetics Society continues to be ever more popular, with more people from more countries using its resources. In the social media such as LinkedIn, the Cancer Epigenetics Society has a larger size audience as that of EpiCypher (founded in 2012), EpiGentek (founded in 2005), and the Max-Planck Institute of Immunobiology and Epigenetics [...]
The Cancer Epigenetics Society is very happy to announce the appointment of Dr. Cigall Kadoch to the Editorial Board of the Cancer Epigenetics journals series. Dr. Kadoch is an expert of ATP-dependent mammalian SWI/SNF chromatin remodeling machineries, with a particular interest in locus-specific and genome-wide modulation by BAF complexes in cancer. Dr. Kadoch is Assistant [...]
The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Lucy Godley to the Editorial Board of the Cancer Epigenetics journals series. Dr. Godley is an expert of myeloid malignancies with a particular interest in DNA methylation and hydroxymethylation role in normal and neoplastic hematopoiesis. She also uses transgenic mouse models to [...]
The Cancer Epigenetics Society is as of July 1, 2017 a Full Member of Epichembio, an EU-funded initiative of the European Cooperation in Science and Technology (COST). Epichembio (Epigenetic Chemical Biology) regroups scientists and research institutions from 34 countries, making it one of the largest international networks in epigenetics research. It is led by [...]
The Cancer Epigenetics Society is now on YouTube with short videos relevant to cancer and/or epigenetics. The Society's first video follows the timeline of DNA-based epigenetics with several findings relevant to cancer biology or treatment. The second video highlights cancer rates in the top 50 most affected countries, showing that cancer is a global [...]
The Cancer Epigenetics Society is as of June 15, 2017, a Full Member of the Union for International Cancer Control (UICC)! UICC is an NGO located in Geneva, Switzerland, that brings together an exclusive worldwide coalition of the major players in cancer control. It works closely with the International Atomic Energy Agency (IAEA), the [...]
The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Raul A. Urrutia as the Society's Chief Science Officer. Dr. Urrutia joins the leadership of the Cancer Epigenetics Society from the Mayo Clinic at Rochester where he holds full Professorships in Medicine, Biochemistry and Molecular Biology, and Biophysics. Dr. Urrutia is [...]
The Cancer Epigenetics Society is happy to announce its partnership with the 3rd Annual Epigenetics Discovery Congress that takes place in London, from the 12th to the 13th of October 2017. The meeting will cover several aspects of epigenetics and cancer epigenetics, including transgenerational epigenetics, novel epigenetic targets, epigenetics in disease and treatment, and single [...]
The Cancer Epigenetics Society is very excited to announce the appointment of Dr. Peter Jones, Chief Scientific Officer of Van Andel Research Institute (VARI, Grand Rapids, MI, USA), as co-Editor-in-Chief of the Cancer Epigenetics journal series. Dr. Jones is a world renown DNA methylation expert who was first to show that 5-azacytidine is a demethylating [...]
The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Jerry Workman to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Workman is an Investigator at the Stowers Institute for Medical Research (Kansas City, MO, USA). Prior to his current position, Dr. Workman was a Fellow at Harvard University [...]
It is with great sadness that we learned of the passing of Dr. Sabine Oberhauser, Health Minister of Austria since 9/2014. Dr. Oberhauser suffered from cancer since early 2015. Not least among her many accomplishments is her commitment to fight cancer by forbiding smoking in restaurants nationwide, which should take effect in May 2018. Dr. [...]
The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Sharon Y. R. Dent to the position of co-Editor-in-Chief of the Cancer Epigenetics (CE) journal series. Dr. Dent is Professor and holds the J. Ralph Meadows Chair of the Department of Epigenetics and Molecular Carcinogenesis at University of Texas MD Anderson Cancer [...]
The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Tatiana Kutateladze to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Kutateladze is a Professor of Pharmacology at the University of Colorado School of Medicine (Aurora, CO, USA). Her research interests include studying epigenetic mechanisms, posttranslational histone modifications, and [...]
The Cancer Epigenetics Society enters into a partnership with Treat Mesothelioma to better support mesothelioma patients worldwide. Treat Mesothelioma is dedicated to the assistance and guidance of asbestos and mesothelioma victims around the world. Treat Mesothelioma is also meant to inspire hope and to provide information and resources to help guide patients and their loved [...]
The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Luciano Di Croce to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Di Croce is the Leader of Epigenetics Events in Cancer Group at the Centre for Genomic Regulation (CGR), an international biomedical research institute of excellence at the [...]
The Cancer Epigenetics Society is happy to announce the official appointment of Dr. Giacomo Cavalli to the position of Editor at Cancer Epigenetics (CE) journal series. Dr. Cavalli is is Head of the Chromatin and Cell Biology Laboratory at the Institute for Human Genetics (Montpellier, France). He is also a Permanent Member of the EpigeneSys [...]
The Cancer Epigenetics Society officially appoints Dr. Jonathan D. Licht, Editor at Cancer Epigenetics (CE) journal series. Dr. Licht is Director of University of Florida Health Cancer Center (Gainesville, FL, USA), and holds the Marshall E. Rinker Sr. Foundation and David B and Leighan R. Rinker Chair. Before that, Dr. Licht was Chief of Hematology/Oncology and [...]
The Cancer Epigenetics Society officially appoints Dr. Keith Robertson, Officer at the Cancer Epigenetics Society and Professor of Molecular Pharmacology & Experimental Therapeutics at Mayo Clinic, Rochester (MN, USA), Vice-President of the Cancer Epigenetics Society. Keith earned his Bachelor’s degree from Cornell University, and his PhD from Johns Hopkins University. He next did his Postdoctoral training [...]
Recent work from several labs have shown ARID1A, the helicase/ATPase-containing SWI/SNF chromatin-remodeling factor, to be mutated in several cancers, most notably in ovarian cancer (some 50% of ovarian clear-cell carcinoma). Other cancers in which ARID1A was reported to be mutated include Sézary syndrome (a leukemic form of cutaneous T cell lymphoma; ~26%), pancreatic cancer (~25%), breast [...]
The Cancer Epigenetics Society enters into a partnership with the Mexican Society of Epigenetics and Regenerative Medicine, thus marking the beginning of a program of collaborations between the Cancer Epigenetics Society and research institutions and societies in Mexico and other Latin American countries. The two societies will be working closely together to further the visibility [...]
The experimental section of the Cancer Epigenetics Drug Database has been expanded to now include a fourth class of epigenetics-targeting drugs: the inhibitors of histone (lysine) demethylases or KDMi. This database currently includes data on 9 KDMi and 61 cancer cell lines. Together, the experimental section of the Cancer Epigenetics Drug Database now includes more [...]
The Cancer Epigenetics Society officially appoints Dr. Susan J. Clark, Professor at University of New South Wales Faculty of Medicine in Sidney, Australia, Editor at Cancer Epigenetics (CE) journal series. Dr. Clark is also Group Leader of the Laboratory for Epigenetics Research, Head of the Genomics and Epigenetics Division, and Head of the Cancer Epigenetics Program at [...]
We at the Cancer Epigenetics Society have lately focused our efforts on expanding the experimental datasets of the Cancer Epigenetics Drug Database with emphasis on three large classes of epigenetics-targeting drugs. These are the inhibitors of the DNA methyltransferases (DNMTi), histone deacetylases (HDACi), and histone methyltransferases (HMTi). Together, the three datasets include more than 2,500 [...]
The Cancer Epigenetics Society has continued expanding its cancer epigenetic drug clinical trial repository which now covers 500+ clinical trials. These include most if not all reported completed, ongoing, and recruiting cancer clinical trials on DNA methyltransferases (DNMTi), histone deacetylases (HDACi), histone methyltransferases (HMTi), and histone demethylases (KDMi). All databases are currently freely accessible to [...]
As a member of the US National Coalition for Cancer Survivorship (NCCS), the Cancer Epigenetics Society asks our members in the States with interest in cancer treatment and survival to help support cancer advocacy in the US. One such initiative is currently undergoing under the umbrella of NCCS to provide a boost to the bipartisan [...]
We have continued to expand our country-specific resources to better cater to the needs of local patients. We now provide resources for Austria, Bulgaria, Canada, Cyprus, Ecuador, France, Greece, Nicaragua, Peru, Portugal, Russia, Slovakia, Turkey, the UK, and the US at the Advocacy & Support Group section. More resources for these and other countries are [...]
Aberrations in the epigenetic phenomenon known as imprinting is a highly frequent early event in tumorigenesis (initiation of cancer) of a large number of tumors including acute myeloid leukemia (AML), Barrett's esophagus, breast cancer, chronic myeloid leukemia (CML), colorectal cancer, esophageal cancer, Ewing's sarcoma, glioma, laryngeal squamous cell carcinoma, hepatoblastoma, lung adenocarcinoma, meningioma, osteosarcoma, ovarian [...]
We recently reported that frequent low-dose intake of aspirin reduces the risk of developing colorectal and bile duct cancers (read it here). Now a new study from Norway shows that taking aspirin after cancer diagnosis improves survival of people diagnosed with colorectal cancer. In a collaboration between the Cancer Registry of Norway, the Norwegian Institute [...]
Regular exercise is known to improve cardiovascular function and to reduce the risk or lessen the impact of stress, depression, high blood pressure, stroke, arthritis, osteoporosis, back pain, as well as obesity and certain forms of diabetes. An international collaborative research from the US, Sweden, Norway, Finland, France, and the UK now shows that regular [...]
Recent research from scientists in the US, Canada, and Europe show that residential radon can increase the risk of hematological cancers, particularly of follicular lymphoma and diffuse large B-cell lymphoma. The study analyzed data from 140,652 people in 20 US states and over nearly two decades that were grouped into low (< 74 Becquerel/m³), medium [...]
We proudly announce that CES has now its own YouTube channel! We have released our first video which gives a quick overview of the history of DNA chemical changes that accompany many different cellular processes, including those involved in cancer. These changes, the most common of which being DNA methylation, represents one of the most [...]
Previous research had unsurprisingly linked high levels of fine particulate matter in breathing air (also known as PM2.5) to lung cancer. A new study links PM2.5 in breathing air to increased risk of several cancers including liver, pancreatic, and breast cancer. For example, women had an 80% increase risk of breast cancer for every 10 [...]
Exposure to high levels of arsenic was already known to increase the risk of bladder cancer. A new study from the National Cancer Institute (NIH/NCI, Bethesda, USA) of well drinking water in Maine, Vermont, and New Hampshire, found that low doses of arsenic in drinking water, presumably from contaminating pesticides, also dramatically increase risk of [...]
After putting together resources for cancer advocacy and support groups that operate internationally, we now also provide country-specific resources that may better cater to the needs of local patients. As of today, Austria, Bulgaria, Canada, the UK, and the US figure now on our cancer Advocacy & Support group section. More support groups for these [...]
